Week of January 17, 2022

This episode discusses six MMWR reports. The first report looks at racial and ethnic disparities in receipt of monoclonal antibodies for the treatment of COVID-19. The next three reports examine the protection provided by COVID-19 vaccines, including booster doses, during periods of Delta and Omicron variant emergence. The fifth report examines updated ACIP guidance for the use of Johnson & Johnson's Janssen COVID-19 vaccine. And the last report looks at early evidence of the Omicron variant in community wastewater.